BridgeBio Pharma BBIO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$729.89M+0.4% | -$732.94M+9.0% | -$805.69M-2.6% | -$785.01M-16.0% | -$676.8M-24.6% | ||
| $5.34M-1.8% | $5.43M+1.3% | $5.37M-2.5% | $5.51M-4.5% | $5.76M-5.1% | ||
| $140.38M+5.5% | $133.02M+3.5% | $128.51M+6.7% | $120.41M+15.1% | $104.63M+9.2% | ||
| -$443.95M+0.4% | -$445.91M+23.8% | -$584.82M+10.8% | -$655.81M— | —— | ||
| $1.17M+6.3% | $1.1M-1.3% | $1.11M+42.8% | $778K+227% | $238K-74.5% | ||
| —— | —— | —— | $23.63M-40.4% | $39.67M-38.0% | ||
| —— | —— | —— | —— | $48.28M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $837.01M+56.5% | $534.97M-29.1% | ||
| $339.28M+405% | -$111.1M-147% | $237.22M— | —— | —— | ||
| -$445.12M+0.4% | -$447.01M+23.7% | -$585.93M+10.8% | -$656.59M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BridgeBio Pharma generate?
- BridgeBio Pharma (BBIO) generated -$444.0M in operating cash flow over the trailing twelve months.
- What is BridgeBio Pharma's free cash flow?
- After $1.2M of capital expenditures, BridgeBio Pharma's free cash flow was -$445.1M over the trailing twelve months, up 44.0% year over year.
- Where does BridgeBio Pharma's cash flow data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
